When comparing the alteration frequencies these genes, EGFR, TP53, SUZ12, and CREBBP were significantly different between gliosarcoma and GBM, (Fisher’s Test, p < 0.05), but none maintained significance when corrected for multiple hypothesis testing (Fig. 3). The gene discussed is EGFR; the disease is gliosarcoma.